18 December 2012

Doctors Should Not Prescribe ADHD Drugs To Healthy People For Neuroenhancement

Physicians are advised stop prescribing medication for ADD and ADHD patients to healthy people for the purpose of enhancing their cognitive abilities (neuroenhancement).

A growing trend for some individuals is to enhance their cognitive capabilities through prescription drugs meant for patients with ADD. These individuals use these medications despite having no diagnosed disorder.

Neuroenhancement is the artificial increase of mental performance using medication. It is also referred to as brain doping. The individual enhances his concentration, alertness, and overall behavior.

Drinking coffee or taking in caffeine may be considered as a practice of neuroenhancement. But caffeine is considered both as a drug and a food additive. It is legal and unregulated in nearly all parts of the world whereas ADD drugs require a prescription.

This practice is more similar to performance enhancing drugs in sports than for recreational use. Questions whether this practice is ethical in the light of academic and professional environments.

Although this practice is not widespread (It is estimated that 1% to 11% of university students take these drugs for cognitive enhancement), there is a danger that this practice may become prevalent.

Doctors advised not to prescribe ADD drugs to healthy people

Physicians in Canada should consider refusing to prescribe cognitive enhancement medications — also used to treat attention deficit disorder (ADD) — to healthy patients, states an analysis article in CMAJ (Canadian Medical Association Journal). Lack of evidence for benefits and possibility of harm, limited health care resources and professional integrity of physicians are reasons why this use is not acceptable.

Prescription stimulants such as methylphenidate and dextroamphetamine are often used by people for "cognitive enhancement" to increase focus, concentration and memory. Because these drugs are available in Canada by prescription only, people must request them from their doctors.

"Physicians are important stakeholders in this debate, given the risks and regulations of prescription drugs and the potential for requests from patients for cognitive enhancers," writes Dr. Eric Racine, Institut de recherches cliniques de Montréal and Université de Montréal, with coauthors.

Video: Ethics of Neuroenhancement

People take prescription stimulants to perform better in school or at work. Prevalence rates of cognitive enhancer use by university students ranges from 1% to 11% in some studies. Risks to taking stimulants include cardiovascular harm, dependence and psychosis. Current evidence has not shown that the desired benefits of enhanced mental performance are achieved with these substances.

"With uncertain benefits and clear harms, it is difficult to support the notion that physicians should prescribe a medication to a healthy individual for enhancement purposes," adds Dr. Racine with Cynthia Forlini, two coauthors of the paper.

Because physicians in Canada provide prescriptions through a publicly funded health care system with expanding demands for care, prescribing cognitive enhancers may not be an appropriate use of resources.

"Given the current state of limited evidence on medical, scientific, social and ethical aspects of cognitive enhancement, we call for greater attention to its appropriateness within existing Canadian health care systems," the authors conclude.


Canadian Medical Association Journal
Institut de Recherches Cliniques de Montréal (IRCM)
Université de Montréal
Coffee Improves Brain Performance In Implicit Recognition of Positive Words and Emotions
Scent of Rosemary Enhances and Improves Brain's Cognitive Performance
Cocoa and Cocoa Products Rich in Flavanols Enhance Brain Functions
Making The Brain Sharper and Overcoming Attentional Blink
Decaffeinated Coffee Improves Brain Metabolism in Patients with Type 2 Diabetes
How Our Brains Keep Us Focused
Cognitive Training May Lead to Neural and Behavioral Improvements in Patients with Schizophrenia
Cognitive Behavioral Therapy (CBT) As An Effective Prevention in the Development of Psychotic Symptoms And Schizophrenia
Patients with Multiple Sclerosis Benefit with Cognitive Rehabilitation Therapy for Improved Brain Performance
Group Settings Can Diminish Expressions of Intelligence, Especially Among Women
Continuous Sleep Favorable In Long Term Memory Consolidation and Enhancement